Legend Biotech Exceeds Earnings Expectations

Quarterly Earnings Surpass Expectations

Legend Biotech has recently released its quarterly earnings results, showcasing a significant beat over analysts' expectations. The company reported an earnings per share (EPS) of ($0.05), outperforming the consensus estimate of ($0.54) by $0.49. This improvement comes despite the company facing a negative net margin of 135.92% and a negative return on equity of 27.91%.